Does NIVOLUMAB Cause Conjunctivitis? 125 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 125 reports of Conjunctivitis have been filed in association with NIVOLUMAB (OPDIVO). This represents 0.1% of all adverse event reports for NIVOLUMAB.
125
Reports of Conjunctivitis with NIVOLUMAB
0.1%
of all NIVOLUMAB reports
18
Deaths
75
Hospitalizations
How Dangerous Is Conjunctivitis From NIVOLUMAB?
Of the 125 reports, 18 (14.4%) resulted in death, 75 (60.0%) required hospitalization, and 15 (12.0%) were considered life-threatening.
Is Conjunctivitis Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for NIVOLUMAB. However, 125 reports have been filed with the FAERS database.
What Other Side Effects Does NIVOLUMAB Cause?
Death (11,216)
Malignant neoplasm progression (9,363)
Off label use (5,208)
Diarrhoea (4,692)
Fatigue (3,709)
Pyrexia (3,454)
Intentional product use issue (3,297)
Rash (2,816)
Nausea (2,805)
Decreased appetite (2,619)
What Other Drugs Cause Conjunctivitis?
DUPILUMAB (5,270)
ADALIMUMAB (457)
METHOTREXATE (385)
ETANERCEPT (306)
PREDNISONE (250)
SECUKINUMAB (237)
RITUXIMAB (222)
SULFAMETHOXAZOLE\TRIMETHOPRIM (218)
INFLIXIMAB (212)
LAMOTRIGINE (199)
Which NIVOLUMAB Alternatives Have Lower Conjunctivitis Risk?
NIVOLUMAB vs NIVOLUMAB\RELATLIMAB-RMBW
NIVOLUMAB vs NIZATIDINE
NIVOLUMAB vs NOMEGESTROL
NIVOLUMAB vs NORDAZEPAM
NIVOLUMAB vs NOREPINEPHRINE